EX-FILING FEES
Published on June 3, 2022
Exhibit 107
Calculation of Filing Fee Table
Form S-8
(Form Type)
NeoGenomics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security Type |
Security
Class
Title
|
Fee Calculation Rule |
Amount Registered(1) |
Proposed Maximum Offering Price Per Share(2) |
Maximum
Aggregate
Offering Price(2)
|
Fee
Rate
|
Amount of Registration Fee |
|||||||||||||||||||||||||||||||||||||
Equity | Common Stock, $0.001 par value per share, reserved for issuance under the Amended and Restated Employee Stock Purchase Plan |
Rule 457(c) and Rule 457(h) | 1,000,000 | $8.40 | $8,400,000 | 0.0000927 | $778.68 | |||||||||||||||||||||||||||||||||||||
Total Offering Amounts | $8,400,000 | $778.68 | ||||||||||||||||||||||||||||||||||||||||||
Total Fee Offsets | $ — | |||||||||||||||||||||||||||||||||||||||||||
Net Fee Due | $778.68 |
(1) |
In accordance with Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement on Form S-8 (the “Registration Statement”) shall be deemed to cover any additional shares of Common Stock, $0.001 par value per share (the “Common Stock”) of NeoGenomics, Inc. (the “Company”) that become issuable under the plans set forth herein by reason of any stock dividend, stock split, recapitalization, or other similar transaction effected that results in an increase to the number of outstanding shares of Registrant’s Common Stock, as applicable.
|
||||
(2) | Estimated in accordance with Rules 457(c) and 457(h) of the Securities Act based upon the average of the high and low sale prices of the Common Stock as reported on the Nasdaq Global Market on May 31, 2022. |